• Featured Product
  • KD/KO Validated

ACLY Monoklonaler Antikörper

ACLY Monoklonal Antikörper für WB, IHC, IF/ICC, ELISA

Wirt / Isotyp

Maus / IgM

Getestete Reaktivität

human, Maus, Ratte

Anwendung

WB, IHC, IF/ICC, IP, ELISA

Konjugation

Unkonjugiert

Publikationen(12)

CloneNo.

1E10D5

Kat-Nr. : 67166-1-Ig

Synonyme

ATP citrate lyase, 1E10D5, ACL, ATP-citrate, ATP-citrate synthase



Geprüfte Anwendungen

Erfolgreiche Detektion in WBJurkat-Zellen, MCF-7-Zellen
Erfolgreiche Detektion in IHChumanes Prostatakarzinomgewebe
Hinweis: Antigendemaskierung mit TE-Puffer pH 9,0 empfohlen. (*) Wahlweise kann die Antigendemaskierung auch mit Citratpuffer pH 6,0 erfolgen.
Erfolgreiche Detektion in IF/ICCA549-Zellen

Empfohlene Verdünnung

AnwendungVerdünnung
Western Blot (WB)WB : 1:1000-1:10000
Immunhistochemie (IHC)IHC : 1:1000-1:4000
Immunfluoreszenz (IF)/ICCIF/ICC : 1:400-1:1600
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Produktinformation

67166-1-Ig bindet in WB, IHC, IF/ICC, IP, ELISA ACLY und zeigt Reaktivität mit human, Maus, Ratten

Getestete Reaktivität human, Maus, Ratte
In Publikationen genannte Reaktivitäthuman, Maus, Ratte
Wirt / Isotyp Maus / IgM
Klonalität Monoklonal
Typ Antikörper
Immunogen ACLY fusion protein Ag7709
Vollständiger Name ATP citrate lyase
Berechnetes Molekulargewicht 121 kDa
Beobachtetes Molekulargewicht 120 kDa
GenBank-ZugangsnummerBC006195
Gene symbol ACLY
Gene ID (NCBI) 47
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Caprylsäure/Ammoniumsulfat-Präzipitation
Lagerungspuffer PBS with 0.02% sodium azide and 50% glycerol
LagerungsbedingungenBei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

ACLY(ATP-citrate synthase) is also named as ACL. It is the primary enzyme responsible for the synthesis of cytosolic acetyl-CoA. ACLY serves as not only a target in oxygenated cells for suppression of lipid synthesis and histone acetylation, but also as a susceptible target in hypoxic cells to restore inhibition of glycolysis. In nonsmall cell lung carcinoma and hepatocellular carcinoma, ACLY is overexpressed compared with normal parenchyma suggesting that ACLY may represent a common target among highly malignant tumors(PMID:19795461). This protein has 2 isoforms produced by alternative splicing.

Protokolle

PRODUKTSPEZIFISCHE PROTOKOLLE
WB protocol for ACLY antibody 67166-1-IgProtokoll herunterladen
IHC protocol for ACLY antibody 67166-1-IgProtokoll herunterladenl
IF protocol for ACLY antibody 67166-1-IgProtokoll herunterladen
STANDARD-PROTOKOLLE
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen

Publikationen

SpeciesApplicationTitle
mouse,humanWB

Adv Sci (Weinh)

Transcriptional Regulation of De Novo Lipogenesis by SIX1 in Liver Cancer Cells

Authors - Ling Li
mouseWB

Phytomedicine

Melittin suppresses ovarian cancer growth by regulating SREBP1-mediated lipid metabolism

Authors - Ruixin Wu
mouseWB

Int Immunopharmacol

ACLY inhibitor reduced Porphyromonas gingivalis-induced pyroptosis by suppressing microtubules acetylation in macrophages

Authors - Huimin Mao
  • KD Validated
mouseWB

Molecules

The Different Mechanisms of Lipid Accumulation in Hepatocytes Induced by Oleic Acid/Palmitic Acid and High-Fat Diet

Authors - Miao Zhang
humanWB

Mediators Inflamm

The Mutual Inhibition of FoxO1 and SREBP-1c Regulated the Progression of Hepatoblastoma by Regulating Fatty Acid Metabolism.

Authors - Yu Hu
humanWB,IP,IF

Cell Death Dis

ARHGEF3 regulates the stability of ACLY to promote the proliferation of lung cancer

Authors - Feifei Zhou

Rezensionen

The reviews below have been submitted by verified Proteintech customers who received an incentive for providing their feedback.


FH

Domenico (Verified Customer) (10-26-2022)

  • Applications: Immunofluorescence
  • Primary Antibody Dilution: 1:100
  • Cell Tissue Type: Sheep embryonic fibroblasts